Opens in a new tab

Dr. Chen Rongchang

Chinese name: 陈荣昌
Chief Physician, Professor, Doctoral Supervisor . Respiratory and Critical Care Medicine
Dr. Chen Rongchang is Professor of Respiratory and Critical Care Medicine at the First Affiliated Hospital of Guangzhou Medical University and former Director of the Guangzhou Institute of Respiratory Health. Former president of the Chinese Thoracic Society, he has led national COPD guidelines and large studies on chronic obstructive pulmonary disease, respiratory infection and non-invasive ventilation.

Private & confidential

No obligation

Coordinated end-to-end by Orisene

over 35 years
Clinical experience in respiratory and critical care medicine
100+ papers
Peer-reviewed publications in respiratory medicine
1 award
National Science and Technology Progress Award (as team member)

  • The Physician

About Dr. Chen Rongchang

Dr. Chen Rongchang is Professor of Respiratory and Critical Care Medicine at the First Affiliated Hospital of Guangzhou Medical University and former Director of the Guangzhou Institute of Respiratory Health. A former president of the Chinese Thoracic Society and chairman of its COPD group, he has devoted more than four decades to chronic obstructive pulmonary disease, asthma and respiratory critical care. He chaired the Chinese Thoracic Society and helped formulate national COPD diagnosis and treatment guidelines, served on the GOLD Science Committee, and led influential research on airway microbiota and lung function decline. He is a State Council Special Allowance expert.
1、Professor of Respiratory and Critical Care Medicine at the First Affiliated Hospital of Guangzhou Medical University
2、Former Director of the Guangzhou Institute of Respiratory Health
3、President of the 10th Congress of the Chinese Thoracic Society and Chairman of its COPD Group
4、Chairman of the COPD Alliance of the Chinese Thoracic Society
5、Member of the GOLD Science Committee and contributor to international COPD guidelines
6、State Council Special Allowance expert and outstanding young and middle-aged expert of the Ministry of Health
7、Director of the Shenzhen Institute of Respiratory Diseases

Dr. Chen Rongchang ’s Three Key Areas of Expertise

Three areas of focused expertise, each supported by a deep subspecialty team, high case volumes and an English-speaking care pathway coordinated by Orisene.

Chronic obstructive pulmonary disease

He diagnoses and treats chronic obstructive pulmonary disease with inhaled therapy, pulmonary rehabilitation and exacerbation prevention, using lung function assessment and long-term follow-up to slow lung function decline, reduce acute exacerbations and improve quality of life for patients at all disease stages.

Asthma and airway disease

He manages asthma, chronic cough and bronchiectasis through evidence-based pharmacotherapy, allergen avoidance and airway inflammation monitoring, tailoring treatment to each patient's phenotype and severity to achieve reliable symptom control, preserve lung function and prevent acute attacks and long-term complications in adults and older patients.

Respiratory critical care and non-invasive ventilation

He treats respiratory failure and severe respiratory infection using non-invasive and invasive mechanical ventilation and weaning strategies, with expertise in respiratory muscle function and diaphragm fatigue, guiding intensive care for critically ill patients with chronic lung disease or acute respiratory deterioration.

More：COPD exacerbation——prevention and treatment; lung infection——diagnosis; pulmonary rehabilitation——programmes; sleep-disordered breathing——assessment; chronic cough——management

  • Clinical Practice & Publications

Selected cases, research & publications

Representative work drawn from documented clinical treatments, publicly indexed literature, and hospital project records, reflecting the depth of this physician's hands-on expertise and academic rigor.
1. Home noninvasive positive pressure ventilation for stable hypercapnic COPD
A randomized controlled trial conducted by the Guangzhou Institute of Respiratory Health that evaluated home noninvasive positive pressure ventilation with built-in monitoring software in patients with stable, severe hypercapnic chronic obstructive pulmonary disease, assessing improvements in arterial blood gases, exacerbation frequency and overall quality of life.
2. Airway microbiome dysbiosis accelerates lung function decline in COPD
A multicenter cohort study investigating how airway bacterial dysbiosis is associated with accelerated decline in lung function among patients with chronic obstructive pulmonary disease, identifying microbial signatures and immune pathways that may guide patient stratification, early intervention and personalized treatment for COPD patients in China.
3. Long-term home noninvasive ventilation and PaCO2 reduction in chronic hypercapnic COPD
A systematic review and meta-analysis of long-term home noninvasive ventilation in patients with chronic hypercapnic respiratory failure due to chronic obstructive pulmonary disease, demonstrating significant reductions in daytime arterial carbon dioxide levels and hospital admissions while informing long-term ventilation strategies for severe COPD care.
4. Prophylactic noninvasive ventilation after thoracic surgery
A clinical study assessing prophylactic noninvasive positive pressure ventilation to prevent postoperative pulmonary complications and acute respiratory failure in patients undergoing thoracic surgery, supporting early ventilatory support as a lung-protective strategy within perioperative respiratory care for high-risk surgical patients prone to respiratory failure.
5. Home noninvasive ventilation combined with pulmonary rehabilitation in COPD
A recent randomized study evaluating whether combining home noninvasive ventilation with structured pulmonary rehabilitation improves exercise capacity, symptom control and long-term clinical outcomes in patients with stable hypercapnic chronic obstructive pulmonary disease, offering an integrated treatment approach for severe COPD patients with chronic respiratory failure.
6. A multicenter randomized trial of home noninvasive ventilation in hypercapnic COPD
A registered multicenter, randomized controlled trial designed to determine whether long-term home noninvasive positive pressure ventilation reduces hospital readmissions and mortality in patients with stable hypercapnic chronic obstructive pulmonary disease, conducted by the Guangzhou respiratory research group to guide noninvasive ventilation therapy.
  • Affiliated Hospital

Where Dr. Chen Rongchang practices

Guangzhou

The First Affiliated Hospital of Guangzhou Medical University

Chinese name: 广州医科大学附属第一医院
Guangzhou Medical University First Affiliated Hospital, founded in 1903 and led by respiratory scientist Academician Zhong Nanshan, hosts the National Respiratory Medical Center and a national key laboratory, offering 13 national key specialties across 2,850 beds as one of China's leading respiratory-care institutions.
Since 1903
123 years of care
2,850
Licensed beds
15
National-level platforms
Host institution
Licensed beds
View Hospital Profile
Appointments with this physician are booked through official hospital channels only, coordinated end-to-end by Orisene.
  • WHY INTERNATIONAL PATIENTS CHOOSE CHINA

Why patients travel to China for treatment

Six reasons international patients now put China on their shortlist — from internationally aligned clinical capability to the policy channels that make treatment here genuinely reachable.

Clinical capability at international standard

Chinese hospitals deliver internationally aligned protocols, performing vast volumes of advanced robotic, minimally invasive, and complex transplant surgeries annually. This massive clinical data and highly specialized workforce ensure world-class outcomes, even for rare and complex cases.

Diagnostics and treatment in days, not months

A full medical workup that typically means months of waiting elsewhere is completed in China within 48–72 hours. Imaging, labs, and multidisciplinary consultations are integrated into a single visit, allowing treatment to commence immediately.

Transparent, itemised pricing

Chinese healthcare offers legally binding, itemised cost estimates before treatment begins, eliminating hidden fees or surprise billing. Due to national centralized procurement, total expenses remain 40–70% lower than comparable care in Western Europe or North America.

Policy channels that open the door

China facilitates access through 240-hour visa-free transit and dedicated medical visa routes. Policies like the Greater Bay Area drug pathway and Boao Lecheng’s pilot zone allow designated hospitals to administer innovative therapies not yet globally approved.
  • International Patient Guide

Consulting this physician, step by step

From the first message to the follow-up after you fly home, one coordinator, no paperwork on your side.
01
Day 0
  • Share your story
    A private consultation with an Orisene advisor, by message, phone or video. Send medical records in any language. Nothing is shared with the hospital yet.
02
Days 1–3
  • Records review & matching
    Orisene translates and presents your case to the right specialist. The hospital returns a tailored care plan, with costs itemised once that plan is confirmed.
03
Days 3–7
  • Your consultation
    Appointments are booked through official hospital channels only. Your navigator accompanies every visit with real-time interpretation, so you can focus on one thing: being cared for.
04
After you fly home
  • Reports & follow-up
    Translated reports and prescriptions delivered within days, remote follow-up coordination with your physicians at home, and a standing line to your navigator.
Orisene offers English and multilingual services, a professional medical interpreter at every consultation, plus translation of your records, reports and prescriptions.

Ready to plan your consultation with Dr. Chen Rongchang?

Send your records in any language. An Orisene advisor will reply within 2 hours, present your case to the right specialist, and return a tailored care plan with itemised costs, before anything is booked. Simple. Private. Efficient.
Contact

Confidential, permanently

Independent — no hospital commission

We never handle medical fees

Information Sources

This physician profile is compiled by the Orisene team from publicly available online sources and verified at the time of publication. Details may change, and physician availability is confirmed at the time of booking.

Disclaimer: This information is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personal medical guidance.

Mention of any specific product, brand, or manufacturer is for informational purposes only and does not constitute an endorsement or recommendation by Dr. Chen Rongchang.